The Valley Desk

Clinical trial reportClinical pharmacology in drug developmentPublished

A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single-Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical pharmacology in drug development
Published
Subject terms
Humans; Injections, Subcutaneous; Area Under Curve; Cross-Over Studies; Syringes; Therapeutic Equivalency; Adult; Middle Aged; Female; Male; Young Adult; Antibodies, Monoclonal, Humanized
PubMed ID
41545605
Added to directory
Source checked

Report a correction or request removal